首页MYGN • NASDAQ
add
巨数遗传
昨日收盘价
$12.91
当日价格范围
$12.51 - $13.09
年度波幅
$12.04 - $29.30
市值
11.53亿 USD
平均交易量
106.76万
市盈率
-
股息率
-
主要交易所
NASDAQ
相关资讯
财务信息
损益表
收入
净收入
(USD) | 2024年9月info | 年同比变化 |
---|---|---|
收入 | 2.13亿 | 11.15% |
经营支出 | 1.68亿 | 4.68% |
净收入 | -2210.00万 | 63.95% |
净利润率 | -10.36 | 67.56% |
每股收益 | 0.06 | 300.00% |
息税折旧摊销前利润 | -220.00万 | 87.36% |
有效税率 | -4.25% | — |
资产负债表
总资产
负债总额
(USD) | 2024年9月info | 年同比变化 |
---|---|---|
现金及短期投资 | 9990.00万 | 15.76% |
总资产 | 10.81亿 | -5.90% |
负债总额 | 3.50亿 | -24.93% |
权益总额 | 7.32亿 | — |
发行在外的股份 | 9103.52万 | — |
市净率 | 1.61 | — |
资产回报率 | -4.11% | — |
资本回报率 | -5.06% | — |
现金流
现金净变动
(USD) | 2024年9月info | 年同比变化 |
---|---|---|
净收入 | -2210.00万 | 63.95% |
来自运营的现金 | 70.00万 | 103.17% |
投资现金 | 750.00万 | 400.00% |
融资现金 | -310.00万 | -24.00% |
现金净变动 | 860.00万 | 131.05% |
自由现金流 | 1627.50万 | 148.95% |
简介
Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to a particular drug therapy, assess a patient's risk of disease progression and disease recurrence, and measure disease activity. Wikipedia
成立时间
1991
总部
员工数量
2,700